CD40 and neoplasm: However, a second round of vaccination to tumor-bearing mice with anti-CD40, polyIC and protein in the context of FTY720, which prevents T cells from leaving lymph nodes, resulted in additional tumor control, indicating that these intratumoral effector T cells were capable of a secondary response to vaccination.